Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127


Eicosanoid signalling pathways in the heart.

Jenkins CM, Cedars A, Gross RW.

Cardiovasc Res. 2009 May 1;82(2):240-9. doi: 10.1093/cvr/cvn346. Epub 2008 Dec 14. Review.


Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction.

Duda MK, O'Shea KM, Tintinu A, Xu W, Khairallah RJ, Barrows BR, Chess DJ, Azimzadeh AM, Harris WS, Sharov VG, Sabbah HN, Stanley WC.

Cardiovasc Res. 2009 Feb 1;81(2):319-27. doi: 10.1093/cvr/cvn310. Epub 2008 Nov 17.


Systems approach with inflammatory exudates uncovers novel anti-inflammatory and pro-resolving mediators.

Serhan CN.

Prostaglandins Leukot Essent Fatty Acids. 2008 Sep-Nov;79(3-5):157-63. doi: 10.1016/j.plefa.2008.09.012. Epub 2008 Nov 12. Review.


Fish, omega-3 polyunsaturated fatty acids, and mortality from cardiovascular diseases in a nationwide community-based cohort of Japanese men and women the JACC (Japan Collaborative Cohort Study for Evaluation of Cancer Risk) Study.

Yamagishi K, Iso H, Date C, Fukui M, Wakai K, Kikuchi S, Inaba Y, Tanabe N, Tamakoshi A; Japan Collaborative Cohort Study for Evaluation of Cancer Risk Study Group.

J Am Coll Cardiol. 2008 Sep 16;52(12):988-96. doi: 10.1016/j.jacc.2008.06.018.


Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial.

Tavazzi L, Maggioni AP, Marchioli R, Barlera S, Franzosi MG, Latini R, Lucci D, Nicolosi GL, Porcu M, Tognoni G; Gissi-HF Investigators.

Lancet. 2008 Oct 4;372(9645):1223-30. doi: 10.1016/S0140-6736(08)61239-8. Epub 2008 Aug 29.


Alpha-linolenic acid and risk of nonfatal acute myocardial infarction.

Campos H, Baylin A, Willett WC.

Circulation. 2008 Jul 22;118(4):339-45. doi: 10.1161/CIRCULATIONAHA.107.762419. Epub 2008 Jul 7. Erratum in: Circulation. 2008 Sep 16;118(12):e492.


Effects of dietary supplementation with fish oil on in vivo production of inflammatory mediators in clinically normal dogs.

LeBlanc CJ, Horohov DW, Bauer JE, Hosgood G, Mauldin GE.

Am J Vet Res. 2008 Apr;69(4):486-93. doi: 10.2460/ajvr.69.4.486.


Omega-3 fatty acids and coronary heart disease risk: clinical and mechanistic perspectives.

Harris WS, Miller M, Tighe AP, Davidson MH, Schaefer EJ.

Atherosclerosis. 2008 Mar;197(1):12-24. Epub 2007 Dec 26. Review.


Metabolic mechanisms in heart failure.

Ashrafian H, Frenneaux MP, Opie LH.

Circulation. 2007 Jul 24;116(4):434-48. Review.


Dietary supplementation with omega-3 PUFA increases adiponectin and attenuates ventricular remodeling and dysfunction with pressure overload.

Duda MK, O'Shea KM, Lei B, Barrows BR, Azimzadeh AM, McElfresh TE, Hoit BD, Kop WJ, Stanley WC.

Cardiovasc Res. 2007 Nov 1;76(2):303-10. Epub 2007 Jul 23.


Increased adiponectin secretion by highly purified eicosapentaenoic acid in rodent models of obesity and human obese subjects.

Itoh M, Suganami T, Satoh N, Tanimoto-Koyama K, Yuan X, Tanaka M, Kawano H, Yano T, Aoe S, Takeya M, Shimatsu A, Kuzuya H, Kamei Y, Ogawa Y.

Arterioscler Thromb Vasc Biol. 2007 Sep;27(9):1918-25. Epub 2007 Jun 14.


Tumor necrosis factor-alpha mediates cardiac remodeling and ventricular dysfunction after pressure overload state.

Sun M, Chen M, Dawood F, Zurawska U, Li JY, Parker T, Kassiri Z, Kirshenbaum LA, Arnold M, Khokha R, Liu PP.

Circulation. 2007 Mar 20;115(11):1398-407. Epub 2007 Mar 12.


Potential impact of carbohydrate and fat intake on pathological left ventricular hypertrophy.

Sharma N, Okere IC, Duda MK, Chess DJ, O'Shea KM, Stanley WC.

Cardiovasc Res. 2007 Jan 15;73(2):257-68. Epub 2006 Nov 11. Review.


Alpha-linolenic acid-enriched diet prevents myocardial damage and expands longevity in cardiomyopathic hamsters.

Fiaccavento R, Carotenuto F, Minieri M, Masuelli L, Vecchini A, Bei R, Modesti A, Binaglia L, Fusco A, Bertoli A, Forte G, Carosella L, Di Nardo P.

Am J Pathol. 2006 Dec;169(6):1913-24.


Fish intake, contaminants, and human health: evaluating the risks and the benefits.

Mozaffarian D, Rimm EB.

JAMA. 2006 Oct 18;296(15):1885-99. Review. Erratum in: JAMA. 2007 Feb 14;297(6):590.


The omega-6/omega-3 ratio and cardiovascular disease risk: uses and abuses.

Harris WS.

Curr Atheroscler Rep. 2006 Nov;8(6):453-9. Review.


Trans geometric isomers of EPA decrease LXRalpha-induced cellular triacylglycerol via suppression of SREBP-1c and PGC-1beta.

Zaima N, Sugawara T, Goto D, Hirata T.

J Lipid Res. 2006 Dec;47(12):2712-7. Epub 2006 Sep 27.

Supplemental Content

Support Center